Ledger.Open graph →
SEC Form D · filed April 30, 2018

Tulavi Therapeutics, Inc

Offering
$3.0M
Sold
$1.8M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
LOS ALTOS HILLS, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (4)

Corinne Bright · Los Altos Hills, CAExec · DirectorFarhad Khosravi · Campbell, CAExec · DirectorFarhad Khosravi · Waltham, MAExec · DirectorCorinne Bright · Los Altos Hills, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗